Latest filing published 17 Dec 2025 for Monopar Therapeutics.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -74.1%Entry US$108.70 · Close at T+365 US$28.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Diane Hendricks: trading record in brief
This profile gathers the share dealings of Diane Hendricks in Monopar Therapeutics. The record holds 2 filings, for trades running from 18 December 2019 to 16 December 2025.
Purchases make up the whole of the open-market record (1 purchase, €3.4M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The newest entry dates from 17 December 2025: a transaction, in Monopar Therapeutics. The latest purchase dates back some time: it was published 2,516 days ago, on 20 December 2019. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Diane Hendricks
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 43,499 shares0Common StockSEC:0001437749-25-038139:0
- 468,750 shares@ US$8.00100.0% of flowCommon stockSEC:0001654954-19-014155:0Canonical exit: 17 Mar 2020 (T+90)
2 of 2 declarations
